🇺🇸 FDA
Patent

US 7524962

Biphenyl compounds useful as muscarinic receptor antagonists

granted A61PA61P11/00A61P11/06

Quick answer

US patent 7524962 (Biphenyl compounds useful as muscarinic receptor antagonists) held by Theravance, Inc. expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P11/00, A61P11/06, A61P43/00